Should I repeat blood cultures when one bottle is positive for Staphylococcus aureus and the other is negative?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you absolutely need to repeat blood cultures when one bottle is positive for Staphylococcus aureus

Repeat blood cultures are a mandatory component of the minimum evaluation for any S. aureus bacteremia, regardless of whether your initial set shows one positive and one negative bottle. 1

Why This Matters for Patient Outcomes

The 2023 Clinical Infectious Diseases guidelines explicitly list "repeat blood cultures" as part of the minimum evaluation for all S. aureus bacteremia cases, alongside thorough history/exam and transthoracic echocardiography 1. This is not optional—it's fundamental to risk stratification and treatment decisions.

Key Clinical Reasoning:

Even a single positive S. aureus culture represents true bacteremia in 85-90% of cases 2, 3. Your scenario of one positive and one negative bottle does not rule out significant infection:

  • 15% of patients with a single positive S. aureus bottle will have positive follow-up cultures 4
  • This rate jumps to 19% for MRSA versus 9% for MSSA 4
  • Importantly, 50% of patients with persistent bacteremia on follow-up cultures are afebrile, so clinical appearance is unreliable 4

The "Skip Phenomenon" Problem

A critical pitfall: 13% of S. aureus bacteremia cases demonstrate intermittent negative blood cultures before complete clearance 5. This means:

  • A single negative culture has only 87-93% predictive value for resolution of bacteremia on days 1-3 5
  • 4% of patients show the skip phenomenon—negative cultures sandwiched between positive ones 6
  • Patients with the skip phenomenon had significantly longer bacteremia duration (median 10 vs 8 days) 6

The clinical consequence: Patients who don't get follow-up cultures have a 17% relapse rate versus 2% in those who do get them (p=0.008) 4.

Practical Implementation

Timing: Obtain follow-up blood cultures at 2-4 days after the initial positive culture and continue as needed until clearance is documented 1.

What constitutes clearance: Do not accept a single negative blood culture as proof of clearance. The evidence strongly suggests obtaining serial negative cultures, particularly if considering the patient for "low-risk" SAB classification or planning device reimplantation 5, 6.

Risk stratification depends on this: Your patient cannot be classified as "low-risk SAB" (which requires blood cultures clearing in <48 hours) without actually documenting clearance 1. Misclassification could lead to inadequate workup for metastatic foci and inappropriate treatment duration.

The Bottom Line

Your initial finding of one positive and one negative bottle for S. aureus does not change standard management. Treat this as S. aureus bacteremia, obtain follow-up cultures at 2-4 days, and continue surveillance cultures until you document clearance with serial negative results. The mortality implications of persistent bacteremia (attributable mortality increases with each day of culture positivity) make this non-negotiable 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.